Ayele, H. T., Douros, A. ., & Filion, K. B. (2022). 5-α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population-based cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15317
A. Douros
First name
A.
Last name
Douros
Douros, A. ., Yin, H. ., H. Y. Yu, O. ., Filion, K. B., Azoulay, L. ., & Suissa, S. . (2017). Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events. Diabetes Care. http://doi.org/10.2337/dc17-0595
Douros, A. ., Dell’Aniello, S. ., H. Y. Yu, O. ., Filion, K. B., Azoulay, L. ., & Suissa, S. . (2018). Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k2693
Douros, A. ., Abrahami, D. ., Yin, H. ., H. Y. Yu, O. ., Renoux, C. ., Hudson, M. ., & Azoulay, L. . (2018). Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes. Epidemiology. http://doi.org/10.1097/ede.0000000000000891
Abrahami, D. ., Douros, A. ., Yin, H. ., Yu, O. H., Faillie, J. L., Montastruc, F. ., … Azoulay, L. . (2018). Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k4880
Douros, A. ., Filion, K. B., Yin, H. ., Yu, O. H., Etminan, M. ., Udell, J. A., & Azoulay, L. . (2018). Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy. Diabetes Care. http://doi.org/10.2337/dc17-2280
Abrahami, D. ., Douros, A. ., Yin, H. ., H. Y. Yu, O. ., Renoux, C. ., Bitton, A. ., & Azoulay, L. . (2018). Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k872
Filion, K. B., Douros, A. ., Azoulay, L. ., Yin, H. ., Yu, O. H., & Suissa, S. . (2019). Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14056
Abrahami, D. ., Douros, A. ., Yin, H. ., H. Y. Yu, O. ., & Azoulay, L. . (2019). Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc19-0849
Douros, A. ., Rouette, J. ., Yin, H. ., H. Y. Yu, O. ., Filion, K. B., & Azoulay, L. . (2019). Dipeptidyl Peptidase-4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc19-0409